Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 5,638 | 5,741 | 5,848 | 5,157 | 4,741 |
| Operating Income | -5,638 | -5,741 | -5,848 | -5,157 | -4,741 |
| Other Income | 526 | 597 | 709 | 693 | 271 |
| Pre-tax Income | -5,112 | -5,144 | -5,139 | -4,464 | -4,470 |
| Income Tax | 7 | 7 | 22 | 7 | 7 |
| Net Income Continuous | -5,119 | -5,151 | -5,161 | -4,471 | -4,477 |
| Net Income | $-5,119 | $-5,151 | $-5,161 | $-4,471 | $-4,477 |
| EPS Basic Total Ops | -0.13 | -0.14 | -0.12 | -0.12 | -0.16 |
| EPS Basic Continuous Ops | -0.13 | -0.14 | -0.11 | -0.12 | -0.16 |
| EPS Diluted Total Ops | -0.13 | -0.14 | -0.12 | -0.12 | -0.16 |
| EPS Diluted Continuous Ops | -0.13 | -0.14 | -0.11 | -0.12 | -0.16 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.14 | -0.14 | -0.12 | N/A |
| EBITDA(a) | $-5,947 | $-6,062 | $-6,207 | $-5,573 | $-4,961 |